Lidocaine Hcl And Epinephrine Injection, Solution
Product Images NDC 51662-1503

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Lidocaine Hcl And Epinephrine (NDC 51662-1503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51662-1503-1 Alternate Vial Label (51662 1503 1 Alternate Vial Label)

FDA Label Image

51662-1503-1 30 mL Serialized Vial Labeling (51662 1503 1 Serialized Labeling)

This is a pharmaceutical product manufactured by an unknown company, represented by a code "10057DK". It is an injection with 2% Lidocaine HCI and 1:100,000 Epinephrine, and its usage is restricted to prescription only. The product is distributed by two companies: HF Acquisition 60, located in Mukilteo, WA 98275, and KOSP Hospira Inc. in Lake Forest, IL 60045 US. Further information can be found on the manufacturer's package insert.*

FDA Label Image

51662-1503-1 Vial Labeling (51662 1503 1 Vial Label)

This is a description of a 30mL solution containing Lidocaine HCI 2%, Epinephrine 1:100,000, NaCl 6 mg, sodium metabisulfite, and other components. It is recommended for infiltration and nerve block use, and is sterile and nonpyrogenic. The dosage instructions can be found in the insert, and it is not to be autoclaved. The solution is not suitable for epidural or caudal use. The solution is distributed by Hospira Inc. and has a LOT number and expiration date.*

FDA Label Image

51662 1503 2 Pouch Label

FDA Label Image

51662 1503 3 Case Labeling

FDA Label Image

51662 1503 3 Rfid Labeling

FDA Label Image

Description (Description)

This is a table showing concentrations of various medications used in medical procedures. The medications listed are Epinephrine, Lidocaine HCL, and Sodium Chloride, with respective concentrations in milligrams per milliliter. The table also includes different "doses" of Lidocaine HCL (in percentages and ratios) and their corresponding concentrations in mg/mL for each drug listed. The concentrations listed range from 5 mg/mL to 65 mg/mL.*

FDA Label Image

Dosage (Dosage)

This is a table showing Recommended Dosages of Lidocaine Hydrochloride Injection for various procedures such as infiltration, nerve blocks, obstetrical analgesia, and anesthesia. The total dose is mentioned in milligrams (ma) and the volume of the dosage is mentioned in mililiters (m). The dermatomes to be anesthetized have been mentioned for certain procedures.*

FDA Label Image

How Supplied 1 (How Supplied 1)

This text provides information about different types of Lidocaine HCL and Epinephrine solutions available in trays, cases or cartons. Each unit shows the concentration and size of the vials or ampuls. Some are single dose, others are multiple doses. There are also some Epidural Test Dose solutions available.*

FDA Label Image

How Supplied Logo (How Supplied Logo)

FDA Label Image

Logo (Logo)

FDA Label Image

Precautions 1 (Precautions 1)

This text provides a list of various drugs categorized by their types. The types mentioned include nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs. The names of drugs belonging to each category are also provided.*

FDA Label Image

Structure 1 (Structure 1)

FDA Label Image

Structure 2 (Structure 2)

FDA Label Image

Vial Label

This is a description of a medication with NDC 0409-3182-21. The medication is a 30mL multiple-dose injection containing Lidocaine HCI, epinephrine, and methylparaben. It may include NaOH and/or HCI for pH adjustment. This medication is for infusion and nerve block, but cannot be used for epidural or caudal use. The injection must be protected from light, and the usual dosage should be followed. The medication is sterile, nonpyrogenic, and should not be autoclaved. The distributor of the medication is Hospira Inc. based in Lake Forest, IL. The description includes a lot number, and the expiration date should be checked.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.